Patents by Inventor Tomoyuki Ando
Tomoyuki Ando has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20100167217Abstract: A method of forming a resist pattern that includes: applying a positive chemically amplified resist composition to a support to form a first resist film, exposing a region on a portion of the first resist film, performing a post exposure bake treatment and then performing developing to form a first resist pattern, and applying a negative chemically amplified resist composition to the support having the first resist pattern formed thereon, thereby forming a second resist film, exposing a region of the second resist film that includes the positions in which the first resist pattern has been formed, performing a post exposure bake treatment at a bake temperature that increases the solubility of the first resist film in an alkali developing solution and decreases the solubility of the second resist film in an alkali developing solution, and then performing developing to form a resist pattern.Type: ApplicationFiled: September 29, 2009Publication date: July 1, 2010Applicant: TOKYO OHKA KOGYO CO., LTD.Inventor: Tomoyuki Ando
-
Patent number: 7727701Abstract: A positive resist composition that exhibits a large exposure margin, and excellent levels of resolution and dry etching resistance, as well as a method of forming a resist pattern that uses the positive resist composition.Type: GrantFiled: January 14, 2005Date of Patent: June 1, 2010Assignee: Tokyo Ohka Kogyo Co., Ltd.Inventors: Takuma Hojo, Kiyoshi Ishikawa, Tomoyuki Ando
-
Patent number: 7687525Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.Type: GrantFiled: November 14, 2007Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma AktiengesellschaftInventors: Tsuneji Suzuki, Tomoyuki Ando, Katsutoshi Tsuchiya, Osamu Nakanishi, Akiko Saito, Takashi Yamashita, Yoshinori Shiraishi, Eishi Tanaka
-
Patent number: 7687221Abstract: Disclosed is a positive resist composition which can provide a positive resist composition and a resist pattern forming method, capable of forming a high resolution pattern with reduce LER, the positive resist composition comprising a resin component (A) which has acid dissociable, dissolution inhibiting groups and exhibits increased alkali solubility under the action of an acid, and an acid generator component (B) which generates an acid under exposure, wherein the resin component (A) contains a polymer compound (A1) having a structural unit (a1) derived from hydroxystyrene and a structural unit (a2) derived from an acrylate ester having acid dissociable, dissolution inhibiting groups, a fluorine atom or a fluorinated lower alkyl group being bonded at the ?-position.Type: GrantFiled: December 14, 2005Date of Patent: March 30, 2010Assignee: Tokyo Ohka Kogyo Co., Ltd.Inventors: Taako Hirosaki, Tomoyuki Ando, Takuma Hojo
-
Publication number: 20100035192Abstract: A method of forming a resist pattern including: forming a resist film on a substrate using a chemically amplified negative resist composition; forming a latent image of a first line and space pattern by subjecting the resist film to first exposure through a photomask; forming a latent image of a second line and space pattern so as to intersect with the latent image of the first line and space pattern by subjecting the resist film to second exposure through a photomask; and subjecting the resist film to developing to form a hole pattern in the resist film.Type: ApplicationFiled: July 31, 2009Publication date: February 11, 2010Applicant: Tokyo Ohka Kogyo Co., Ltd.Inventors: Tomoyuki Ando, Sho Abe, Ryoji Watanabe, Komei Hirahara
-
Publication number: 20090214808Abstract: A container holding member to hold a container includes a basket-shaped mesh body which has a closed-end. The basket-shaped mesh body is formed by weaving a plurality of strands to be arranged diagonally with respect to a central axis of the mesh body. Each of the strands includes a plurality of carbon fibers. A matrix is filled in interstices between the plurality of carbon fibers.Type: ApplicationFiled: February 25, 2009Publication date: August 27, 2009Applicant: IBIDEN CO., LTD.Inventors: Hideki KATO, Haruhide Shikano, Tomoyuki Ando, Masahiro Yasuda
-
Publication number: 20090211518Abstract: A crucible holding member includes a hollow mesh body. The hollow mesh body has an upper end opening and a lower end opening, and includes a plurality of strands woven to be arranged diagonally to a central axis of the hollow mesh body. Each of the strands includes a plurality of carbon fibers. A matrix is filled in the interstices between the carbon fibers.Type: ApplicationFiled: February 19, 2009Publication date: August 27, 2009Applicant: IBIDEN CO., LTD.Inventors: Hideki KATO, Haruhide Shikano, Tomoyuki Ando, Masahiro Yasuda
-
Publication number: 20090211517Abstract: A crucible holding member includes a mesh body which includes a plurality of strands woven each including a plurality of carbon fibers. The mesh body has a triaxial weave structure including a plurality of first strands, a plurality of second strands and a plurality of third strands. The plurality of first strands are provided in a first direction inclined at a first angle with respect to a central axis of the mesh body. The plurality of second strands are provided so that the plurality of first strands and the plurality of second strands are substantially symmetrical with respect to the central axis. The plurality of third strands are provided substantially along the central axis. A matrix is filled in interstices between the carbon fibers.Type: ApplicationFiled: February 25, 2009Publication date: August 27, 2009Applicant: IBIDEN CO., LTD.Inventors: Hideki KATO, Haruhide Shikano, Tomoyuki Ando, Masahiro Yasuda
-
Patent number: 7510861Abstract: A novel gluconate dehydratase derived from Achromobacter xylosoxidans and a gene encoding the gluconate dehydratase are provided. By reacting the gluconate dehydratase or a transformed cell containing the gene with an aldonic acid, the corresponding 2-keto-3-deoxyaldonic acid can be efficiently produced.Type: GrantFiled: September 20, 2006Date of Patent: March 31, 2009Assignee: Mitsui Chemicals, Inc.Inventors: Hitoki Miyake, Toshifumi Yamaki, Toshihiro Oikawa, Takeshi Nakamura, Hiroki Ishibashi, Yasushi Fukuiri, Atsushi Sakuma, Hironori Komatsu, Tomoyuki Ando, Kazuhiko Togashi, Hideki Umetani
-
Publication number: 20090075177Abstract: A positive resist composition having excellent size controllability, and a resist pattern forming method are provided. This positive resist composition contains a resin component (A) comprising an alkali soluble constituent unit (a1) which comprises a constituent unit (a11) derived from (?-methyl)hydroxystyrene, and a constituent unit (a2) which has an acid dissociable dissolution inhibiting group including an acid dissociable dissolution inhibiting group (II) represented by the following general formula (II) and/or a specific chain acid dissociable dissolution inhibiting group (III); an acid generator component (B) which generates an acid upon exposure; and preferably contains an aromatic amine (C).Type: ApplicationFiled: November 28, 2005Publication date: March 19, 2009Applicant: TOKYO OHKA KOGYO CO., LTD.Inventors: Tomoyuki Ando, Takako Hirosaki
-
Publication number: 20090047600Abstract: Disclosed is a positive resist composition which can provide a positive resist composition and a resist pattern forming method, capable of forming a high resolution pattern with reduce LER, the positive resist composition comprising a resin component (A) which has acid dissociable, dissolution inhibiting groups and exhibits increased alkali solubility under the action of an acid, and an acid generator component (B) which generates an acid under exposure, wherein the resin component (A) contains a polymer compound (A1) having a structural unit (a1) derived from hydroxystyrene and a structural unit (a2) derived from an acrylate ester having acid dissociable, dissolution inhibiting groups, a fluorine atom or a fluorinated lower alkyl group being bonded at the ?-position.Type: ApplicationFiled: December 14, 2005Publication date: February 19, 2009Applicant: TOKYO OHKA KOGYO CO., LTD.Inventors: Takako Hirosaki, Tomoyuki Ando, Takuma Hojo
-
Publication number: 20080241747Abstract: A positive resist composition that exhibits a large exposure margin, and excellent levels of resolution and dry etching resistance, as well as a method of forming a resist pattern that uses the positive resist composition.Type: ApplicationFiled: January 14, 2005Publication date: October 2, 2008Applicant: TOKYO OHKA KOGYO CO., LTD.Inventors: Takuma Hojo, Kiyoshi Ishikawa, Tomoyuki Ando
-
Publication number: 20080241753Abstract: The negative resist composition of the present invention comprises a silsesguioxane resin (A) comprising a constituent unit (a1) represented by the following general formula (I) and a constituent unit (a2) represented by the following general formula (II), an acid generator component (B) which generates an acid upon exposure, and a crosslinking agent component (C): wherein R1 represents a linear or branched alkylene group having 1 to 5 carbon atoms, andType: ApplicationFiled: March 11, 2005Publication date: October 2, 2008Inventor: Tomoyuki Ando
-
Publication number: 20080188489Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.Type: ApplicationFiled: November 14, 2007Publication date: August 7, 2008Applicant: Schering AktiengesellschaftInventors: Tsuneji Suzuki, Tomoyuki Ando, Katsutoshi Tsuchiya, Osamu Nakanishi, Akiko Saito, Takashi Yamashita, Yoshinori Shiraishi, Eishi Tanaka
-
Patent number: 7318992Abstract: A lift-off positive resist composition capable of forming a fine lift-off pattern is provided. This composition comprises a base resin component (A) and an acid generator component (B) generating an acid under exposure, wherein the base resin component (A) is a silicone resin.Type: GrantFiled: March 28, 2005Date of Patent: January 15, 2008Assignee: Tokyo Ohka Kogyo Co., Ltd.Inventors: Daisuke Kawana, Tomotaka Yamada, Hiroshi Shimbori, Koki Tamura, Tomoyuki Ando, Takayuki Hosono
-
Patent number: 7317028Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.Type: GrantFiled: January 9, 2004Date of Patent: January 8, 2008Assignee: Schering AktiengesellschaftInventors: Tsuneji Suzuki, Tomoyuki Ando, Katsutoshi Tsuchiya, Osamu Nakanishi, Akiko Saito, Takashi Yamashita, Yoshinori Shiraishi, Eishi Tanaka
-
Publication number: 20070015265Abstract: A novel gluconate dehydratase derived from Achromobacter xylosoxidans and a gene encoding the gluconate dehydratase are provided. By reacting the gluconate dehydratase or a transformed cell containing the gene with an aldonic acid, the corresponding 2-keto-3-deoxyaldonic acid can be efficiently produced.Type: ApplicationFiled: September 20, 2006Publication date: January 18, 2007Applicant: Mitsui Chemicals, Inc.Inventors: Hitoki Miyake, Toshifumi Yamaki, Toshihiro Oikawa, Takeshi Nakamura, Hiroki Ishibashi, Yasushi Fukuiri, Atsushi Sakuma, Hironori Komatsu, Tomoyuki Ando, Kazuhiko Togashi, Hideki Umetani
-
Publication number: 20070009828Abstract: A positive resist composition, comprising a resin component (A) that exhibits increased alkali solubility under the action of acid, and an acid generator component (B) that generates acid on exposure, wherein the component (A) includes either a silsesquioxane resin (A1) containing structural units (a1) represented by a general formula (I) shown below, structural units (a2) represented by a general formula (II) shown below, and structural units (a3) represented by a general formula (III) shown below, or a silsesquioxane resin (A2) containing structural units (al) represented by the general formula (I) shown below, and structural units (a2?) represented by a general formula (II?) shown below.Type: ApplicationFiled: June 11, 2004Publication date: January 11, 2007Applicant: TOKYO OHKA KOGYO, CO., LTD.Inventors: Koki Tamura, Daisuke Kawana, Tomotaka Yamada, Takayuki Hosono, Taku Hirayama, Kazufumi Sato, Hiroshi Shimbori, Tomoyuki Ando
-
Patent number: RE39754Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.Type: GrantFiled: August 14, 2003Date of Patent: July 31, 2007Assignee: Schering AGInventors: Tsuneji Suzuki, Tomoyuki Ando, Katsutoshi Tsuchiya, Osamu Nakanishi, Akiko Saito, Takashi Yamashita, Yoshinori Shiraishi, Eishi Tanaka
-
Patent number: RE40703Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.Type: GrantFiled: October 3, 2006Date of Patent: April 28, 2009Assignee: Schering AktiengesellschaftInventors: Tsuneji Suzuki, Tomoyuki Ando, Katsutoshi Tsuchiya, Osamu Nakanishi, Akiko Saito, Takashi Yamashita, Yoshinori Shiraishi, Eishi Tanaka